This inventor holds 1 USPTO granted patent and 17 published patent applications. Top assignee: The University of Texas System. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: David Marin Costa: Innovator in Cell Immunotherapy
Introduction
David Marin Costa is a prominent inventor based in Houston, TX (US). He has made significant contributions to the field of cancer treatment through his innovative work in cell immunotherapy. His research focuses on utilizing immune effector cells, particularly natural killer (NK) cells, to combat various types of cancer.
Latest Patents
David Marin Costa holds a patent for "Cell immunotherapy for the treatment of cancer." This patent encompasses compositions that include immune effector cells, such as NK cells, which are enhanced with exogenously provided interleukins (IL). Notably, the patent specifies that the IL is not IL-15, but may include IL-12, IL-21, or both. The NK cells developed through this research can be utilized for the treatment of various cancers, including glioblastoma.
Career Highlights
David Marin Costa is affiliated with The University of Texas System, where he continues to advance his research in immunotherapy. His work is pivotal in the ongoing fight against cancer, showcasing the potential of engineered immune cells in therapeutic applications.
Collaborations
David collaborates with esteemed colleagues, including Katy Rezvani and Mayra Shanley, who contribute to the research and development of innovative cancer treatments.
Conclusion
David Marin Costa's contributions to cell immunotherapy represent a significant advancement in cancer treatment. His innovative approach and dedication to research continue to inspire progress in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile